Afrox Healthcare/Afrox/Bidco - Update as to timing for the Competition Tribunal
hearing
Afrox Healthcare Limited Business Venture Investments
(Incorporated in the No. 790 (Proprietary)
Republic of South Africa) Limited
(Registration number: (Incorporated in the
1985/001313/06) Republic of South Africa)
Share code: AHH (Registration number:
ISIN: ZAE000022059 2003/002733/07)
("Ahealth") ("Bidco")
African Oxygen Limited
(Incorporated in the
Republic of South Africa)
(Registration number
1927/000089/06)
Share code: AFX
ISIN: ZAE000030920
("Afrox")
Joint announcement from Ahealth, Bidco and Afrox as to timing for the
Competition Tribunal hearing
As announced on Tuesday 20 April 2004 by Afrox, the Competition Commission
recommended, to the Competition Tribunal, that the merger of Bidco and Ahealth
(the "merger") be approved subject to certain conditions.
Bidco comprises a BEE consortium and Medi-Clinic Corporation Limited. The BEE
consortium comprises Brimstone Investment Corporation Limited, Mvelaphanda
Strategic Investments (Proprietary) Limited, and broad based empowerment
groupings.
In terms of an order issued by the Competition Tribunal, the hearing of the
merger by the Competition Tribunal is scheduled to take place over the week of
19 - 23 July 2004. The approval by the Competition Tribunal is the only
outstanding condition precedent for the acquisition by Bidco of all the shares
in Ahealth.
Johannesburg
13 May 2004
Sponsor to Afrox and Ahealth
Nedbank Capital
Date: 13/05/2004 02:49:03 PM Produced by the JSE SENS Department
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
